NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00332020,"Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement",https://clinicaltrials.gov/study/NCT00332020,RECORD 2,COMPLETED,"The purpose of this study is to assess if 10 mg BAY 59-7939, taken once daily as a tablet, is safe and can help prevent blood clots forming after a hip replacement operation.",NO,Prevention|Venous Thromboembolism,DRUG: Rivaroxaban (BAY59-7939)|DRUG: Enoxaparin,"Composite endpoint of total VTE i.e.: Any DVT (proximal and/or distal), Non fatal PE, Death of all causes, Treatment period: up to day 35+/-6","Incidence of the composite endpoint comprising proximal DVT, non-fatal PE and VTE- related death (major VTE), Treatment period: up to day 35+/-6|Incidence of symptomatic VTE (DVT, PE), Treatment period: up to day 35+/-6|Incidence of DVT (total, proximal, distal), Treatment period: up to day 35+/-6|Incidence of symptomatic VTE during follow-up, Follow-up period: following 35+/-6 days|The composite endpoint comprising major VTE and treatment-emergent major bleeding, For major VTE, treatment period: up to Day 35+/-6 ; for major bleeding, from first dose of double-blind study medication to up to two days after last dose of double-blind study medication|Incidence of the composite endpoint that results from the primary endpoint by substituting VTE related death for all death, Treatment period: up to day 35+/-6|Incidence of the composite endpoint that results from major VTE by substituting all cause mortality for VTE-related death, Treatment period: up to day 35+/-6|Treatment-emergent major bleedings, From first dose of double-blind study medication to up to two days after last dose of double-blind study medication",,Bayer,,ALL,"ADULT, OLDER_ADULT",PHASE3,2457,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",11357|2005-004691-20,2006-02,2007-05,2007-06,2006-05-31,,2015-01-27,"Birmingham, Alabama, 35205, United States|Denver, Colorado, 80222, United States|Bay Pines, Florida, 33744, United States|Miami, Florida, 33186, United States|Oklahoma City, Oklahoma, 73103, United States|Canberra, Australian Capital Territory, 2605, Australia|Lismore, New South Wales, 2480, Australia|Sydney, New South Wales, 2065, Australia|Southport, Queensland, 4215, Australia|Geelong, Victoria, 3220, Australia|Melbourne, Victoria, 3128, Australia|Belo Horizonte, Minas Gerais, 30170-132, Brazil|Belo Horizonte, Minas Gerais, 30380 090, Brazil|Curitiba, Paraná, 80050-350, Brazil|Passo Fundo, Rio Grande do Sul, 99010-100, Brazil|Batatais, Sao Paulo, 14300 000, Brazil|Marília, Sao Paulo, 17515-900, Brazil|Sao Paulo, SP, 04023-900, Brazil|Rio de Janeiro, Brazil|Sao Paulo, 0122-1020, Brazil|Sao Paulo, 04262-000, Brazil|Red Deer, Alberta, T4N 4E7, Canada|Penticton, British Columbia, V2A 5C8, Canada|Winnipeg, Manitoba, R3J 3M7, Canada|St. John, New Brunswick, E2L 4L2, Canada|Oshawa, Ontario, L1G 2B9, Canada|Ottawa, Ontario, K1H 8L6, Canada|Ottawa, Ontario, K1Y 4E9, Canada|Scarborough, Ontario, M1M 3W3, Canada|Scarborough, Ontario, M1P 2V5, Canada|Thunder Bay, Ontario, P7B 6V4, Canada|Windsor, Ontario, N9A 1E1, Canada|Guangzhou,, Guangdong, 510405, China|Jinan, Shandong, 250014, China|Qingdao, Shandong, 266003, China|Xi'an, Shanxi, 710004, China|Beijing, 100035, China|Beijing, 100044, China|Beijing, 100853, China|Shanghai, 200025, China|Shanghai, 200032, China|Shanghai, 200233, China|Shanghai, 200433, China|Barranquilla, Colombia|Bogotá, Colombia|Cali, Colombia|Medellín, Colombia|Copenhagen, 2300, Denmark|Copenhagen, 2400, Denmark|Frederiksberg, 2000, Denmark|Glostrup, 2600, Denmark|Herlev, 2730, Denmark|Holbaek, 4300, Denmark|Hvidovre, 2650, Denmark|Silkeborg, 8600, Denmark|Viborg, 8800, Denmark|Tallinn, 10138, Estonia|Tartu, 51014, Estonia|Hyderabad, Andhra Pradesh, 500034, India|Secundrabad, Andra Pradesh, 500003, India|Ludhiana, Punjab, 141001, India|Bangalore, 560001, India|Bangalore, 560034, India|Mumbai, 400012, India|Bandung, West Java, 40161, Indonesia|Surabaya, Indonesia|Genova, 16132, Italy|Lecco, 23900, Italy|Modena, 41100, Italy|Napoli, 80131, Italy|Parma, 43100, Italy|Siena, 53100, Italy|Udine, 33100, Italy|Daegu, 700721, Korea, Republic of|Kyunggido, 471710, Korea, Republic of|Seoul, 135-710, Korea, Republic of|Seoul, 138-736, Korea, Republic of|Liepaja, 3402, Latvia|Riga, Latvia|Kaunas, 44320, Lithuania|Klaipeda, 92288, Lithuania|Panevezys, 35144, Lithuania|Siauliai, 76231, Lithuania|Chihuahua, Chih., Chihuahua, 31000, Mexico|Guadalajara, Jalisco, 44280, Mexico|Auckland, 0622, New Zealand|Auckland, 1023, New Zealand|Kongsvinger, 2212, Norway|Namsos, 7800, Norway|Oslo, 0264, Norway|Oslo, 0440, Norway|Tynset, 2501, Norway|Callao, CALLAO 2, Peru|Lima Cercado, LIMA 1, Peru|Lima, 01, Peru|Lima, 31, Peru|Lima, LIMA 11, Peru|Lima, LIMA 1, Peru|Lisboa, 1069-166, Portugal|Porto, 4200-319, Portugal|Setúbal, 299-182, Portugal|Torres Vedras, 2560-324, Portugal|Bloemfontein, Freestate, 9300, South Africa|Johannesburg, Gauteng, 2132, South Africa|Randburg, Gauteng, 2125, South Africa|Newcastle, Kwa Zulu-Natal, 2940, South Africa|Cape Town, Western Cape, 7505, South Africa|Falköping, 521 85, Sweden|Hässleholm, 281 25, Sweden|Kungälv, 442 83, Sweden|Lidköping, 531 85, Sweden|Stockholm, 112 81, Sweden|Sundsvall, 851 86, Sweden|Varberg, 432 81, Sweden|Växjö, 351 85, Sweden|Örebro, 701 85, Sweden|Kaohsiung, 833, Taiwan|Taoyuan, 333, Taiwan|Chesterfield, Derbyshire, S44 5BL, United Kingdom|Dumfries, Dumfries and Galloway, DG1 4EP, United Kingdom|Kirkcaldy, Fife, KY2 5AH, United Kingdom|London, Greater London, SE5 9RS, United Kingdom|Liverpool, Merseyside, L14 3LB, United Kingdom|Great Yarmouth, Norfolk, NR31 6LA, United Kingdom|Northampton, Northamptonshire, NN1 5BD, United Kingdom|Epsom, Surrey, KT18 7EG, United Kingdom",
